RIPK1 and neoplasm: On the other hand, activated caspase-8 promotes the expression of RIPK1 (receptor-interacting serine/threonine-protein kinase 1), inhibits the activation of NF-κB pathway, and inhibits the proliferation of tumor cells (12).